Obesity

Continuing from the first ESE Talks webinar about diabetes, in this second webinar Professor Bulent Yildiz (Turkey) will discuss the related subject of obesity and its interaction with the COVID-19 pandemic.

The webinar will provide an overview of the risks and outcomes facing obese patients who contract COVID-19. The wider implications and challenges of treating and managing obesity during the pandemic will also be outlined.

The key learning points of this talk include:

  1. Critical review of emerging clinical data on the association of obesity and risk, progression and outcome of COVID-19
  2. Potential pathophysiological mechanisms linking obesity and COVID-19
  3. Challenges in evaluation and management of obese patient with COVID-19
  4. Coronavirus pandemic public health measures and obesity
  5. Implications for surveillance and future research

 This webinar has now passed, and can be viewed below. 

Andrea Giustina: President, 2019-2021 (Chair)

Andrea Giustina: President, 2019-2021 (Chair)

Dr. Giustina received his medical degree with distinction from the University of Brescia (Italy) in 1986. At the University of Brescia he rose to become Full Professor of Internal Medicine in 2007. He moved to San Raffaele Vita-Salute University in Milano in January 2017 where he is full Professor of Endocrinology and Metabolism and Pro Rector for Institutional and International Affairs. He is Director of Postgraduate Program in Endocrinology and Metabolism at San Raffaele University and Head of the Division of Endocrinology at San Raffaele Hospital. Dr Giustina has authored more than 400 original papers and made seminal contributions to our understanding of mechanisms regulating growth secretion, as well as disorders of both growth hormone deficiency and excess and bone neuroendocrinology. He elucidated the “Giustina effect” defined as inhibition of growth hormone secretion in the absence of circulating cortisol and its reversibility when cortisol levels are restored to normal. He also has co-authored several pituitary medicine guidelines of which those on Acromegaly criteria of cure and Cushing disease diagnosis have been cited more than 1000 times. He was Editor-in-Chief of Endocrine, and one Editor of Pituitary, is President of the European Society of Endocrinology and Past President of the Pituitary Society and served on the Executive Committee of the International Society of Endocrinology. He also served on the Journal managing subcommittee of the Endocrine Society and on the Editorial Board of JCE&M and Clinical Endocrinology. He is a member of the Italian Superior Health Council at the Italian Ministry of Health.

Bulent Yildiz (Turkey)

Bulent Yildiz (Turkey)

Bulent Yildiz is Professor of Medicine / Endocrinology and Metabolism at Hacettepe University School of Medicine, Ankara, Turkey. He earned his medical degree from Hacettepe University and did his postdoctoral studies at University of California at Los Angeles where he also completed a National Institutes of Health training program in translational investigation. His clinical and research interests involve obesity and androgen excess disorders in women including polycystic ovary syndrome. He has published over 100 original articles, reviews and book chapters, and is an editorial board member for several international journals. Dr. Yildiz has served in various committees of Endocrine Society and the European Society of Endocrinology. He was a Board Member of Androgen Excess and PCOS Society and the General Secretary of the Society of Endocrinology and Metabolism of Turkey. He chaired the Program Organizing Committee of the 19th European Congress of Endocrinology (ECE2017). He is currently Executive Committee Member and Officer of the European Society of Endocrinology. Among his awards and recognitions, Dr. Yildiz is a recipient of the Eisenhower Fellowship for international leadership from The Eisenhower Foundation. Fellowship of Dr. Yildiz focused on the academia-government-industry relations on research, public policy and healthcare delivery for the prevention and management of chronic diseases, specifically diabetes and obesity.

Subscribe to our email alerts